Anika Therapeutics (ANIK) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.20 -1.53%
EPS Growth %: +115.4%
Financial Fact:
Diluted weighted average common shares outstanding: 15.08M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: +115.4%
Financial Fact:
Diluted weighted average common shares outstanding: 15.08M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q4 EPS of $0.54, $0.01 better than the analyst estimate of $0.53. Revenue for the quarter came in at $28.7 million versus the consensus estimate of $27.84 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- FirstCash to acquire UK pawn operator Ramsdens for £206 million
- NVE Corporation names new CEO and expands board to seven members
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
